Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
H.R. 5160
119th CongressPassed HouseStem Cell Therapeutic and Research Reauthorization Act of 2025
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Sponsored by Christopher H. Smith (Republican-NJ-4)
Actions
Considered under suspension of the rules.
DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Motion to reconsider laid on the table Agreed to without objection.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
Placed on the Union Calendar, Calendar No. 629.
Committee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
Subcommittee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
